Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

  • Stefania Gori,
  • Alessandro Inno,
  • Elena Fiorio,
  • Jennifer Foglietta,
  • Antonella Ferro,
  • Marcella Gulisano,
  • Graziella Pinotti,
  • Marta Gubiotti,
  • Maria Giovanna Cavazzini,
  • Monica Turazza,
  • Simona Duranti,
  • Valeria De Simone,
  • Laura Iezzi,
  • Giancarlo Bisagni,
  • Simon Spazzapan,
  • Luigi Cavanna,
  • Chiara Saggia,
  • Emilio Bria,
  • Elisabetta Cretella,
  • Patrizia Vici,
  • Daniele Santini,
  • Alessandra Fabi,
  • Ornella Garrone,
  • Antonio Frassoldati,
  • Laura Amaducci,
  • Silvana Saracchini,
  • Lucia Evangelisti,
  • Sandro Barni,
  • Teresa Gamucci,
  • Lucia Mentuccia,
  • Lucio Laudadio,
  • Alessandra Zoboli,
  • Fabiana Marchetti,
  • Giuseppe Bogina,
  • Gianluigi Lunardi,
  •  [ ... ],
  • Luca Boni
  • [ view all ]
  • [ view less ]

There is an error in the second to last sentence of the Conclusion. The correct sentence is: It should be emphasized, however, that in the adjuvant systemic therapy without trastuzumab group 94% of tumors were hormone receptor positive and 89% of patients were treated with endocrine therapy only.

Reference

  1. 1. Gori S, Inno A, Fiorio E, Foglietta J, Ferro A, Gulisano M, et al. (2015) The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer. PLoS ONE 10(9): e0136731. pmid:26340098

Citation: Gori S, Inno A, Fiorio E, Foglietta J, Ferro A, Gulisano M, et al. (2015) Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer. PLoS ONE 10(9): e0139650. https://doi.org/10.1371/journal.pone.0139650

Published: September 25, 2015

Copyright: © 2015 Gori et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited